From: An integrated bioinformatics analysis to dissect kinase dependency in triple negative breast cancer
 | Top 5 Drugs (Score) ranked by K-Map | ||||
---|---|---|---|---|---|
TNBC Cell Line | Rank 1 | Rank 2 | Rank 3 | Rank 4 | Rank 5 |
BT20 | Staurosporine | Bosutinib | Go 6976 | TWS119 | PKR Inhibitor |
 | (1.00) | (0.976) | (0.972) | (0.963) | (0.953) |
BT549 | Staurosporine | K-252a | SB 218078 | CDK1/2 Inhibitor III | Go 6976 |
 | (1.00) | (1.00) | (0.997) | (0.995) | (0.995) |
CAL148 | Lestaurtinib | K-252a | Staurosporine | JAK3 Inhibitor VI | CDK1/2 Inhibitor III |
 | (1.00) | (1.00) | (1.00) | (0.996) | (0.994) |
HCC38 | Staurosporine | K-252a | CDK1/2 Inhibitor III | SB 218078 | Go 6976 |
 | (1.00) | (1.00) | (0.995) | (0.991) | (0.989) |
HCC70 | Lestaurtinib | Staurosporine | CDK1/2 Inhibitor III | K-252a | SB 218078 |
 | (1.00) | (1.00) | (0.998) | (0.998) | (0.983) |
HCC1143 | JNK Inhibitor II | CDK4 Inhibitor III | CDK4 Inhibitor II | VEGFR Receptor Inhibitor II | CHK2 Inhibitor II |
 | (0.977) | (0.943) | (0.938) | (0.936) | (0.929) |
HCC1187 | Staurosporine | CDK1/2 Inhibitor III | JAK3 Inhibitor VI | JNJ-7706621 | PKR Inhibitor |
 | (1.00) | (0.998) | (0.990) | (0.973) | (0.971) |
HCC1806 | Bosutinib | TWS119 | Staurosporine | Dasatinib | WHI-P154 |
 | (1.00) | (0.990) | (0.98) | (0.966) | (0.956) |
HS578T | Staurosporine | SU11652 | K-252a | Sunitinib | Dorsomorphin |
 | (1.00) | (0.992) | (0.986) | (0.984) | (0.982) |
MDA-MB-231 | CDK1/2 Inhibitor III | Indirubin Derivative E804 | Sunitinib | Aminopurvalanol A | CDK2 Inhibitor IV |
 | (1.00) | (0.975) | (0.956) | (0.949) | (0.94) |
MDA-MB-468 | Lestaurtinib | Staurosporine | CDK1/2 Inhibitor III | K-252a | JAK3 Inhibitor VI |
 | (1.00) | (1.00) | (0.998) | (0.998) | (0.99) |
MFM-223 | Staurosporine | CDK1/2 Inhibitor III | K-252a | JAK3 Inhibitor VI | SYK Inhibitor |
 | (1.00) | (1.00) | (0.99) | (0.974) | (0.972) |